News | February 25, 2010

Interactive Symposium Focuses On Atrial Fibrillation

February 25, 2010 — A case-based interactive symposium will explore clinical correlations and controversies in the area of atrial fibrillation.

The event, titled "Clinical Correlates and Clinical Controversies in Atrial Fibrillation: Has the Balance Shifted?" includes a registration and dinner portion as well as the scientific program, will take place from 6 p.m. to 8:45 p.m. on Monday, March 15, 2010 at The Hyatt Regency Atlanta Centennial Ballroom IV in Atlanta.

The activity is aimed at cardiologists and other healthcare professionals caring for patients with nonvalvular atrial fibrillation (AF).

Educational objectives include defining the specific goals of AF therapy in different clinical circumstances; assessing the role of novel antiarrhythmic agents in AF; outlining criteria for selecting patients best suited for catheter ablation of AF; summarizing the rate vs. rhythm control debtate and discussing whether new approaches to rhythm control militate in its favor; and maximizing clinical benefit in the management of patients with nonvalvular AF.

The event is jointly sponsored by The University of Cincinnati and The Exeter Group.

For more information or to register: www.thrombo.net/balance


Related Content

News | EP Lab

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

Home February 02, 2024
Home
News | EP Lab

January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...

Home January 11, 2024
Home
News | EP Lab

September 22, 2023 — Innovative Health, Inc. launched a new educational initiative and free online tool to help hospital ...

Home September 22, 2023
Home
News | EP Lab

August 17, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home August 17, 2023
Home
News | EP Lab

March 28, 2023 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home March 28, 2023
Home
News | EP Lab

Nov. 4, 2022 — CathVision, a medical technology company developing innovative electrophysiology solutions to enhance ...

Home November 05, 2022
Home
News | EP Lab

October 14, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch of ...

Home October 14, 2022
Home
Feature | EP Lab | By Vijay Kundekar

Arrhythmias can be described as irregular heart rhythms that are brought on by numerous factors, including heart damage ...

Home August 23, 2022
Home
News | EP Lab

May 24, 2022 — Attune Medical, a pioneering medical device company with a technology platform based on temperature ...

Home May 24, 2022
Home
News | EP Lab

May 4, 2022 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home May 04, 2022
Home
Subscribe Now